Cohort study2017Open access

Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia

Shirai Y, Okugawa Y, Hishida A, Ogawa A, Okamoto K, Shintani M, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K, Urata H, Toiyama Y, Inoue Y, Tanaka M, Mohri Y, Goel A, Kusunoki M, McMillan DC, Miki C

Scientific reports · 65 citations

How it was studied

Design
Cohort study (indexed by PubMed)
Studied in
People
Main outcome
Clinical events such as disease or death

Who paid for it

Funding
Independent funding

Based on full-text disclosure statement.

Publication

Published
2017-06-30 · Sci Rep · vol. 7 · issue 1 · p. 4826
Publisher
Nature Portfolio
Cited
83 citations · more than 95% of similar papers · 4.6× the field average
Impact
Top 10% most cited in its field
References
32 works
Access
Open access (journal) · CC-BY
Research areas
Nutrition and Health in Aging · Frailty in Older Adults · GDF15 and Related Biomarkers
Keywords
Cachexia, Medicine, Fish oil, Gastrointestinal cancer, Chemotherapy, Bioelectrical impedance analysis, Cancer, Internal medicine, Lean body mass, Systemic inflammation, Gastroenterology, Eicosapentaenoic acid, Oncology, Inflammation, Polyunsaturated fatty acid, Colorectal cancer, Body mass index, Biology, Body weight, Fatty acid, Fish <Actinopterygii>
MeSH
humans, gastrointestinal neoplasms, inflammation, cachexia, dietary fats, unsaturated, eicosapentaenoic acid, fish oils, c-reactive protein, carcinoembryonic antigen, antineoplastic combined chemotherapy protocols, antigens, tumor-associated, carbohydrate, prognosis, survival analysis, cohort studies, body composition, nutritional status, aged, female, male, biomarkers, tumor

19 authors

From JP, US, GB

  • Yumiko Shirai
  • Yoshinaga Okugawa · correspondingMie University; Baylor University Medical Center; Baylor Scott & White Research Institute
  • Asahi HishidaNagoya University
  • Aki Ogawa
  • Kyoko Okamoto
  • Miki Shintani

Abstract

Despite recent advances in chemotherapy for gastrointestinal cancer, a crucial factor related to poor prognosis is reduced tolerance to chemotherapy induced by cancer cachexia. Fish oil (FO)-derived eicosapentaenoic acid (EPA) modulates inflammation in patients with various malignancies; however, the impact of FO-enriched nutrition as a combined modality therapy on clinical outcomes remains controversial. We systemically analysed chronological changes in biochemical and physiological status using bioelectrical impedance analysis in 128 gastrointestinal cancer patients provided with or without FO-enriched nutrition during chemotherapy. Furthermore, we evaluated the clinical significance of FO-enriched nutrition and clarified appropriate patient groups that receive prognostic benefits from FO-enriched nutrition during treatment of gastrointestinal cancer. The control group showed significant up-regulation of serum CRP) levels and no significant difference in both skeletal muscle mass and lean body mass. In contrast, the FO-enriched nutrition group showed no changes in serum CRP concentration and significantly increased skeletal muscle mass and lean body mass over time. Furthermore, high CRP levels significantly correlated with reduced tolerance to chemotherapy, and FO-enriched nutrition improved chemotherapy tolerance and prognosis, particularly in gastrointestinal cancer patients with a modified Glasgow prognostic score (mGPS) of 1 or 2. We conclude that FO-enriched nutrition may improve the prognosis of patients with cancer cachexia and systemic inflammation (i.e., those with a mGPS of 1 or 2).

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.